We found that the proportions of both CD90+ and CD271+ cells, previously identified as ESCC T-ICs [31, 32], were increased among chemoresistant ESCC cells, suggesting the existence of multiple T-IC subpopulations within ESCC tumors. The gene discussed is NGFR; the disease is esophageal squamous cell carcinoma.